Loading viewer...
earnings
Format: PDF earnings
Fourth quarter 2016 earnings presentation with financial highlights including 12.9% revenue growth driven by $89 million portfolio growth in finance receivables. The presentation discusses GAAP and non-GAAP net income results, provision for credit losses, and key operating metrics.
investor_presentation
18 Pages
earnings
40 Pages
Babcock International Group
Acadia Pharmaceuticals Q4 2025 Earnings Call
earningsearnings
20 Pages
ACADIA Pharmaceuticals
Alijarah Holding Q2 2023 Results Investor Conference
earningsearnings
8 Pages
Alijarah Holding Company